Loreal, FR0000120321

Loreal stock heads toward its October 22 sales update

Published on 10/07/2026 at 13:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Loreal stock heads toward its October 22 sales update after UBS raised its target to EUR 440 on October 6, 2026. First-half revenue reached EUR 23.77 billion.

Trading-Floor mit großen Bildschirmen, die CAC 40 und Euronext Paris Charts zeigen — Dieses Börsen-Editorial illustriert den Handel mit Aktien von L'Oréal S.A., notiert unter ISIN FR0000120321, Illustration mit AI erstellt.

Loreal stock was trading at EUR 373.70 on Euronext Paris on October 7, 2026, at 1:28 p.m. CEST, up 0.03 percent from EUR 373.60. The next company checkpoint is L'Oreal's September sales release on October 22, 2026, after the market close, according to L'Oreal Finance.

UBS lifts its price target

UBS kept its Buy rating and raised its L'Oreal price target from EUR 430 to EUR 440 on October 6, 2026, according to Ideal Investisseur. The new target stands 17.7 percent above the October 7 price, creating a quantified gap between the latest market quotation and the broker's revised valuation.

The same report puts the median analyst target at EUR 440. That median is identical to UBS's revised objective, although the publication does not provide a complete analyst count or target range for L'Oreal.

First-half growth sets the baseline

L'Oreal reported first-half 2026 revenue of EUR 23.77 billion, an increase of 5.8 percent from the prior-year period, according to Yahoo Finance. The result gives the October sales update a concrete comparison point, because investors can measure the third-quarter pace against the first-half growth rate.

The investor-relations calendar lists EUR 44.05 billion of fiscal-year 2025 revenue and a EUR 7.20 dividend per share approved on April 24, 2026, according to L'Oreal Finance. Those figures provide historical context, while the September sales release will supply the next operating data point.

Shares remain below the yearly high

The EUR 373.70 quotation is 7.9 percent below the 52-week high of EUR 405.80 and EUR 34.85 above the 52-week low of EUR 338.85. The company has a market capitalization of EUR 199.0 billion and volume of 36,287 shares on October 7, 2026.

For investors, the central near-term comparison is clear: the market price remains below UBS's EUR 440 target, while the next company-reported sales figure arrives on October 22.